Mga Batayang Estadistika
| CIK | 1863362 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Procaps Group S.A.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| September 3, 2025 |
npawaivermar24 Execution Version 4889-3678-4050 v4 ACTIVE 696347336v3 WAIVER AND FOURTH AMENDMENT TO NOTE PURCHASE AND GUARANTEE AGREEMENT THIS WAIVER AND FOURTH AMENDMENT TO NOTE PURCHASE AND GUARANTEE AGREEMENT (this “Agreement”), dated as of March 29, 2024, is entered into by and among Procaps S. |
|
| September 3, 2025 |
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Procaps Group, S.A. (the “Company”) on Form 20-F for the fiscal year ended December 31, 2023, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Melissa Angelini, Chief Executive |
|
| September 3, 2025 |
Table of Content UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITI |
|
| September 3, 2025 |
insidertradingpolicy 1 ACTIVE 689344382v3 INSIDER TRADING POLICY (Effective as of October 13, 2023) PURPOSE It is illegal for any employee, contractor, officer or director of Procaps Group, S. |
|
| September 3, 2025 |
executiveofficerclawback 1 Procaps Group, S.A. Executive Officer Clawback Policy Approved by the Board of Directors on November 20th, 2023 (the “Adoption Date”) I. Purpose This Executive Officer Clawback Policy describes the circumstances under which Covered Persons of Procaps Group, S.A. and any of its direct or indirect subsidiaries (the “Company”) will be required to repay or return Erroneously |
|
| September 3, 2025 |
Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Procaps Group, S.A. (the “Company”) on Form 20-F for the fiscal year ended December 31, 2023, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Daniel Bernal , Interim Chief Fina |
|
| September 3, 2025 |
Exhibit 12.1 CERTIFICATION I, Melissa Angelini, certify that: 1.I have reviewed this annual report on Form 20-F of Procaps Group, S.A.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect t |
|
| September 3, 2025 |
npawaiverdec23 Execution Version 4868-6487-8489 v3 ACTIVE 691960632v4 WAIVER AGREEMENT THIS WAIVER AGREEMENT (this “Agreement”), dated as of December 29, 2023, is entered into by and among Procaps S. |
|
| September 3, 2025 |
Exhibit 12.2 CERTIFICATION I, Daniel Bernal, certify that: 1.I have reviewed this annual report on Form 20-F of Procaps Group, S.A.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to t |
|
| August 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxemb |
|
| July 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembou |
|
| May 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| May 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-40851 CUSIP NUMBER L7756P 102 (Check one): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tr |
|
| April 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: |
|
| April 14, 2025 |
Exhibit 10.3 PROCAPS GROUP, S.A. SUBSCRIPTION AGREEMENT by and between Procaps Group, S.A. and Compañía de Seguros de Vida Consorcio Nacional de Seguros S.A. as of April 3, 2025 Procaps Group, S.A. SUBSCRIPTION AGREEMENT This Subscription Agreement (this “Agreement”) is made as of April 3, 2025 (the “Effective Date”), by and between Procaps Group, S.A., a public limited liability company (société |
|
| April 14, 2025 |
FORM OF ORDINARY SHARE PURCHASE WARRANT Procaps Group, S.A. Exhibit 10.8 EXHIBIT C NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECT |
|
| April 14, 2025 |
Exhibit 10.2 Execution version PROCAPS GROUP, S.A. SUBSCRIPTION AGREEMENT by and between Procaps Group, S.A. and Flying Fish Ventures L.P. Saint Thomas Commercial S.A. and Santana S.A. as of April 3, 2025 Procaps Group, S.A. SUBSCRIPTION AGREEMENT This Subscription Agreement (this “Agreement”) is made as of April 3, 2025 (the “Effective Date”), by and among Procaps Group, S.A., a public limited li |
|
| April 14, 2025 |
AMENDMENT NO. 1 TO THE SECURED CONVERTIBLE NOTE SUBSCRIPTION AGREEMENT Exhibit 10.7 AMENDMENT NO. 1 TO THE SECURED CONVERTIBLE NOTE SUBSCRIPTION AGREEMENT THIS AMENDMENT NO. 1 TO THE SECURED CONVERTIBLE NOTE SUBSCRIPTION AGREEMENT, (this “Amendment”), which shall be effective as of April 3, 2025 (the “Effective Date”), is entered into by and between Procaps Group, S.A., a public limited liability company (société anonyme) incorporated and existing under the laws of t |
|
| April 14, 2025 |
FORM OF AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT Exhibit 10.12 EXECUTION VERSION FORM OF AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 24, 2025, is made and entered into by and among Procaps Group, S.A., a public limited liability company (société anonyme) incorporated and existing under the laws of the Grand Duchy of Luxembourg, having its registe |
|
| April 14, 2025 |
Exhibit 10.6 PROCAPS GROUP, S.A. SUBSCRIPTION AGREEMENT by and between Procaps Group, S.A. and Corales, LLC as of April 3, 2025 Procaps Group, S.A. SUBSCRIPTION AGREEMENT This Subscription Agreement (this “Agreement”) is made as of April 3, 2025 (the “Effective Date”), by and between Procaps Group, S.A., a public limited liability company (société anonyme) incorporated and existing under the laws |
|
| April 14, 2025 |
Exhibit 10.14 Execution Version PARI PASSU INTERCREDITOR AGREEMENT dated as of April 9, 2025 among PROCAPS S.A., as the Company, PROCAPS GROUP, S.A., as Parent, THE OTHER GRANTORS FROM TIME TO TIME PARTY HERETO, GLAS AMERICAS LLC, as Collateral Agent, the Secured Parties from time to time hereto, and each WC Priority Debt Representative from time to time party hereto. TABLE OF CONTENTS Page ARTICL |
|
| April 14, 2025 |
Exhibit 10.4 PROCAPS GROUP, S.A. SUBSCRIPTION AGREEMENT by and between Procaps Group, S.A. and BTG Pactual Chile S.A. Corredores de Bolsa as of April 3, 2025 Procaps Group, S.A. SUBSCRIPTION AGREEMENT This Subscription Agreement (this “Agreement”) is made as of April 3, 2025 (the “Effective Date”), by and between Procaps Group, S.A., a public limited liability company (société anonyme) incorporate |
|
| April 14, 2025 |
Exhibit 10.1 Execution version PROCAPS GROUP, S.A. SUBSCRIPTION AGREEMENT by and between Procaps Group, S.A. and Chemo Project SA and Becaril S.A. as of April 3, 2025 Procaps Group, S.A. SUBSCRIPTION AGREEMENT This Subscription Agreement (this “Agreement”) is made as of April 3, 2025 (the “Effective Date”), by and among Procaps Group, S.A., a public limited liability company (société anonyme) inco |
|
| April 14, 2025 |
Exhibit 10.11 PROCAPS GROUP, S.A. SUBSCRIPTION AND CONVERSION AGREEMENT by and between Procaps Group, S.A. and Flying Fish Ventures L.P. Saint Thomas Commercial S.A. and Santana S.A. as of April 9, 2025 Procaps Group, S.A. SUBSCRIPTION AND CONVERSION AGREEMENT This Subscription and Conversion Agreement (this “Agreement”) is made as of April 9, 2025, by and between Procaps Group, S.A., a public lim |
|
| April 14, 2025 |
Exhibit 10.13 Execution Version PROCAPS S.A. US$116,488,204.60 6.75% Guaranteed Senior SECURED Notes due December 31, 2029 Guaranteed by PROCAPS GROUP, S.A., as Parent Guarantor, AND certain Subsidiary Guarantors AMENDED AND RESTATED Note Purchase and Guarantee Agreement Dated APRIL 9, 2025 (amending and restating that certain Note Purchase and Guarantee Agreement dated November 5, 2021, as amende |
|
| April 14, 2025 |
Exhibit 10.10 PROCAPS GROUP, S.A. SUBSCRIPTION AND CONVERSION AGREEMENT by and between Procaps Group, S.A. and Chemo Project SA and Becaril S.A. as of April 9, 2025 Procaps Group, S.A. SUBSCRIPTION AND CONVERSION AGREEMENT This Subscription and Conversion Agreement (this “Agreement”) is made as of April 9, 2025, by and between Procaps Group, S.A., a public limited liability company (société anonym |
|
| April 14, 2025 |
Exhibit 10.5 PROCAPS GROUP, S.A. SUBSCRIPTION AGREEMENT by and between Procaps Group, S.A. and Regina International LP as of April 3, 2025 Procaps Group, S.A. SUBSCRIPTION AGREEMENT This Subscription Agreement (this “Agreement”) is made as of April 3, 2025 (the “Effective Date”), by and between Procaps Group, S.A., a public limited liability company (société anonyme) incorporated and existing unde |
|
| April 14, 2025 |
Exhibit 10.9 PROCAPS GROUP, S.A. SUBSCRIPTION AND CONVERSION AGREEMENT by and between Procaps Group, S.A. and Hoche Partners Pharma Holding S.A. as of April 9, 2025 Procaps Group, S.A. SUBSCRIPTION AND CONVERSION AGREEMENT This Subscription and Conversion Agreement (this “Agreement”) is made as of April 9, 2025, by and between Procaps Group, S.A., a public limited liability company (société anonym |
|
| April 9, 2025 |
Exhibit 99.1 Procaps Group Secures $130 Million in Equity Investment and Completes Comprehensive Debt Restructuring, as New Investors Take Over Strategic Leadership New Investors Take Over the Strategic Leadership as Headquarters Move to Bogotá, Marking the Start of a New Chapter of Growth, Execution, and Transformation under Enhanced Governance Company Accelerates Turnaround with Leadership Chang |
|
| April 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: |
|
| March 25, 2025 |
STATUTS COORDONNÉS AU 24 MARS 2025 Exhibit 99.1 Procaps Group, S.A. Société anonyme Siège social : 9, rue de Bitbourg, L-1273 Luxembourg R.C.S. Luxembourg : B253360 STATUTS COORDONNÉS AU 24 MARS 2025 A. NAME - PURPOSE - DURATION - REGISTERED OFFICE Article 1 Name - Legal form There exists a public limited company (société anonyme) under the name Procaps Group, S.A. (the “Company”) which shall be governed by the law of 10 August 191 |
|
| March 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: |
|
| March 6, 2025 |
Exhibit 99.1 Dear Shareholders, We are in regret to inform you that the extraordinary general meeting of shareholders of Procaps Group, S.A., a public limited liability company (societe anonyme) incorporated and existing under the laws of the Grand Duchy of Luxembourg, having its registered office at 9, rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg, and registered with the Luxembou |
|
| March 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: |
|
| March 6, 2025 |
Exhibit 99.2 YOUR VOTE IS IMPORTANT. PLEASE VOTE TODAY. Vote by Internet - QUICK EASY IMMEDIATE - 24 Hours a Day, 7 Days a Week or by Mail Your Internet vote authorizes the Company Proxies PROCAPS GROUP, S.A. (as defined below) to vote your shares in the same manner as if you marked, signed and returned your proxy card . Votes submitted electronically over the Internet must be received by 1 : 52 p |
|
| February 19, 2025 |
Exhibit 99.2 PROCAPS GROUP, S.A. FOLD HERE • DO NOT SEPARATE • INSERT IN ENVELOPE PROVIDED PROXY EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF PROCAPS GROUP, S.A. société anonyme Registered office: 9, rue de Bitbourg, L - 1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B 253360 (the “ Company ”) to be held on Friday, March 7, 2025 at 7 p.m. Luxembourg time (the “Extraordinary G |
|
| February 19, 2025 |
Exhibit 99.1 Dear Shareholders, We are pleased to inform you that an extraordinary general meeting of shareholders (the “Extraordinary General Meeting”) of Procaps Group, S.A., a public limited liability company (société anonyme) incorporated and existing under the laws of the Grand Duchy of Luxembourg, having its registered office at 9, rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembour |
|
| February 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| February 3, 2025 |
Procaps Group Receives Delisting Notice From Nasdaq Exhibit 99.1 Procaps Group Receives Delisting Notice From Nasdaq MIAMI, USA – BARRANQUILLA, COL – February 3, 2025 – Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) that it has determined to delist the Company’s o |
|
| February 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| January 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxem |
|
| January 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxem |
|
| January 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg |
|
| January 3, 2025 |
Procaps Group Receives Additional Delinquency Letter Exhibit 99.1 Procaps Group Receives Additional Delinquency Letter MIAMI, USA – BARRANQUILLA, COL – January 3, 2025 – Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that, as anticipated, on December 31, 2024, the Company received notice from The Nasdaq Stock Market LLC (“Nasdaq”) of an addit |
|
| December 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| December 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| December 20, 2024 |
Exhibit 99.2 Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates MIAMI, USA & BARRANQUILLA, Colombia – December 20, 2024 – Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced significant outcomes from its recent Shareholders Meeting and su |
|
| December 20, 2024 |
STATUTS COORDONNÉS AU 16 DECEMBRE 2024 Exhibit 99.1 Procaps Group, S.A. Société anonyme Siège social : 9, rue de Bitbourg, L-1273 Luxembourg R.C.S. Luxembourg : B253360 STATUTS COORDONNÉS AU 16 DECEMBRE 2024 A. NAME - PURPOSE - DURATION - REGISTERED OFFICE Article 1 Name - Legal form There exists a public limited company (société anonyme) under the name Procaps Group, S.A. (the “Company”) which shall be governed by the law of 10 August |
|
| December 3, 2024 |
Exhibit 99.3 EXECUTION VERSION AGREEMENT DATED November 29, 2024 PROCAPS GROUP S.A “Pledgor” and HOCHE PARTNERS PHARMA HOLDING S.A. “Pledgee” and CRYNSSEN PHARMA GROUP LTD “Company” Share Pledge Agreement TABLE OF CONTENTS Page 1. Definitions and Interpretation 2 2. Constitution of Pledge 3 3. Covenants 4 4. Termination and Release of Pledge 5 5. Voting, Powers, Dividends, Capital Distributions an |
|
| December 3, 2024 |
PROCAPS GROUP, S.A. SECURED CONVERTIBLE NOTE SUBSCRIPTION AGREEMENT Exhibit 99.1 EXECUTION VERSION PROCAPS GROUP, S.A. SECURED CONVERTIBLE NOTE SUBSCRIPTION AGREEMENT This Secured Convertible Note Subscription Agreement (this “Agreement”) is made as of November 29, 2024 by and between Procaps Group, S.A., a public limited liability company (société anonyme) incorporated and existing under the laws of the Grand Duchy of Luxembourg, having its registered office at 9 |
|
| December 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| December 3, 2024 |
PROC / Procaps Group S.A. / Hoche Partners Pharma Holding S.A. - SCHEDULE 13D/A Activist Investment SC 13D/A 1 procaps13da13.htm SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 13) Procaps Group, S.A. (Name of Issuer) Ordinary Shares, nominal value of $0.01 per share (Title of Class of Securities) L7756P 102 (Ordinary Shares) (CUSIP Number) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duc |
|
| December 3, 2024 |
Exhibit 99.2 EXECUTION VERSION THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER SECURITIES ACT, OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION, AND NEITHER THE SECURITIES NOR ANY INTEREST THEREIN MAY BE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR SUCH LAWS OR AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT AND SU |
|
| December 3, 2024 |
Procaps Group Announces Financing, Shareholders Agreement and Board Updates Exhibit 99.5 Procaps Group Announces Financing, Shareholders Agreement and Board Updates MIAMI, USA & BARRANQUILLA, Colombia – December 3, 2024 – Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced the successful execution of key strategic transactions and governance updates aimed at strengtheni |
|
| December 3, 2024 |
FORM OF ORDINARY SHARE PURCHASE WARRANT Procaps Group, S.A. Exhibit 99.4 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST |
|
| November 29, 2024 |
Exhibit 99.3 |
|
| November 29, 2024 |
Exhibit 99.1 Dear Shareholders, We are pleased to inform you that an extraordinary general meeting of shareholders (the “Extraordinary General Meeting”) and an annual general meeting of shareholders (the “Annual General Meeting”) of Procaps Group, S.A., a public limited liability company (société anonyme) incorporated and existing under the laws of the Grand Duchy of Luxembourg, having its registe |
|
| November 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| November 29, 2024 |
Exhibit 99.2 |
|
| November 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| November 15, 2024 |
Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing Exhibit 99.1 Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing MIAMI, USA & BARRANQUILLA, Colombia – November 15, 2024 – Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), announced today that, on November 13, 2024, the Company received formal notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LL |
|
| November 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| November 1, 2024 |
Procaps Issues Shareholder Letter Update Exhibit 99.1 Procaps Issues Shareholder Letter Update MIAMI, USA & BARRANQUILLA, Colombia – November 1, 2024 – Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services, today issued the below letter to shareholders from José Antonio Vieira, CEO of Procaps, key updates on our recent board changes, progress on forbearance arra |
|
| October 29, 2024 |
EX-99.24 2 ex9924.htm EXHIBIT 99.24 Exhibit 99.24 Peter Flagel Director Gibbons P.C. One Pennsylvania Plaza 45th Floor, Suite 4515 New York, NY 10119 Direct: 212-613-2091 Fax: +1 212-554-9685 [email protected] October 29, 2024 VIA EMAIL Procaps Group S.A. 9 Rue De Bitbourg L-1273 Luxembourg Grand Duchy of Luxembourg Mr. Jose Antonio Vieira, Chief Executive Officer Board of Directors: Mr. Kyle |
|
| October 29, 2024 |
PROC / Procaps Group S.A. / Hoche Partners Pharma Holding S.A. - SCHEDULE 13D/A Activist Investment SC 13D/A 1 procaps13da12.htm SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 12) Procaps Group, S.A. (Name of Issuer) Ordinary Shares, nominal value of $0.01 per share (Title of Class of Securities) L7756P 102 (Ordinary Shares) (CUSIP Number) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duc |
|
| October 28, 2024 |
EX-99.23 2 ex9923.htm EXHIBIT 99.23 Exhibit 99.23 VIA EMAIL To: The Board of Directors of Procaps Group, S.A. (the “Board”) Procaps Group, S.A 9, rue De Bitbourg L-1273 Luxembourg Grand Duchy of Luxembourg (the “Company” or “Procaps”) October 28, 2024 Dear Board Members, Following our last letter to you on October 10, 2024, Hoche Partners Pharma Holding S.A. (“Hoche”) has made a clear offer to re- |
|
| October 28, 2024 |
PROC / Procaps Group S.A. / Hoche Partners Pharma Holding S.A. - SCHEDULE 13D/A Activist Investment SC 13D/A 1 procaps13da11.htm SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 11) Procaps Group, S.A. (Name of Issuer) Ordinary Shares, nominal value of $0.01 per share (Title of Class of Securities) L7756P 102 (Ordinary Shares) (CUSIP Number) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duc |
|
| October 10, 2024 |
EX-99.22 2 ex9922.htm EXHIBIT 99.22 Exhibit 99.22 VIA EMAIL PRIVILEGED AND CONFIDENTIAL To: The Board of Directors of Procaps Group, S.A. (the “Board”) Procaps Group, S.A 9, rue De Bitbourg L-1273 Luxembourg Grand Duchy of Luxembourg (the “Company” or “Procaps”) October 10, 2024 Dear Board Members, Hoche Partners Pharma Holding S.A. (“Hoche”) has just reviewed the Company’s press release on Form 6 |
|
| October 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg |
|
| October 10, 2024 |
PROC / Procaps Group S.A. / Hoche Partners Pharma Holding S.A. - SCHEDULE 13D/A Activist Investment SC 13D/A 1 procaps13da10.htm SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 10) Procaps Group, S.A. (Name of Issuer) Ordinary Shares, nominal value of $0.01 per share (Title of Class of Securities) L7756P 102 (Ordinary Shares) (CUSIP Number) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duc |
|
| October 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg |
|
| September 19, 2024 |
PROC / Procaps Group S.A. / Hoche Partners Pharma Holding S.A. - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 9) Procaps Group, S.A. (Name of Issuer) Ordinary Shares, nominal value of $0.01 per share (Title of Class of Securities) L7756P 102 (Ordinary Shares) (CUSIP Number) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B253360 T |
|
| September 19, 2024 |
Procaps Issues Shareholder Letter Update Exhibit 99.18 Procaps Issues Shareholder Letter Update MIAMI, USA & BARRANQUILLA, Colombia – September 18, 2024 – Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services, today issued the below letter to shareholders from José Antonio Vieira, CEO of Procaps, with updates on the Company’s restructuring and strategic plan pro |
|
| September 19, 2024 |
Exhibit 99.20 Peter Flagel Director Gibbons P.C. One Pennsylvania Plaza 45th Floor, Suite 4515 New York, NY 10119 Direct: 212-613-2091 Fax: +1 212-554-9685 [email protected] September 18, 2024 VIA EMAIL Procaps Group S.A. 9 Rue De Bitbourg L-1273 Luxembourg Grand Duchy of Luxembourg Mr. Jose Antonio Vieira, Chief Executive Officer Board of Directors: Mr. Kyle P. Bransfield Mr. Luis Fernando C |
|
| September 19, 2024 |
Procaps Issues Shareholder Letter Exhibit 99.19 Procaps Issues Shareholder Letter MIAMI, USA & BARRANQUILLA, Colombia – September 3, 2024 – Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today issued the below letter to shareholders from José Antonio Vieira, CEO of Procaps, addressing the current state of the business and outlining key strateg |
|
| September 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembou |
|
| September 18, 2024 |
Procaps Issues Shareholder Letter Update Exhibit 99.1 Procaps Issues Shareholder Letter Update MIAMI, USA & BARRANQUILLA, Colombia – September 18, 2024 – Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services, today issued the below letter to shareholders from José Antonio Vieira, CEO of Procaps, with updates on the Company’s restructuring and strategic plan proj |
|
| September 4, 2024 |
PROC / Procaps Group S.A. / Hoche Partners Pharma Holding S.A. - SCHEDULE 13D/A Activist Investment SC 13D/A 1 procaps13da8.htm SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 8) Procaps Group, S.A. (Name of Issuer) Ordinary Shares, nominal value of $0.01 per share (Title of Class of Securities) L7756P 102 (Ordinary Shares) (CUSIP Number) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy |
|
| September 4, 2024 |
EX-99.17 2 ex9917.htm EXHIBIT 99.17 Exhibit 99.17 VIA EMAIL PRIVILEGED AND CONFIDENTIAL To: The Board of Directors of Procaps Group, S.A. (the “Board”) Procaps Group, S.A 9, rue De Bitbourg L-1273 Luxembourg Grand Duchy of Luxembourg (the “Company” or “Procaps”) September 3, 2024 Dear Sirs: Dear Board Members, Hoche Partners Pharma Holding S.A. (“Hoche”), has just read the Company’s press release |
|
| September 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembou |
|
| September 3, 2024 |
Procaps Issues Shareholder Letter Exhibit 99.1 Procaps Issues Shareholder Letter MIAMI, USA & BARRANQUILLA, Colombia – September 3, 2024 – Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today issued the below letter to shareholders from José Antonio Vieira, CEO of Procaps, addressing the current state of the business and outlining key strategi |
|
| August 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: |
|
| August 23, 2024 |
PROC / Procaps Group S.A. / Hoche Partners Pharma Holding S.A. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 7) Procaps Group, S.A. (Name of Issuer) Ordinary Shares, nominal value of $0.01 per share (Title of Class of Securities) L7756P 102 (Ordinary Shares) (CUSIP Number) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B253360 T |
|
| August 12, 2024 |
PROC / Procaps Group S.A. / Hoche Partners Pharma Holding S.A. - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 6) Procaps Group, S.A. (Name of Issuer) Ordinary Shares, nominal value of $0.01 per share (Title of Class of Securities) L7756P 102 (Ordinary Shares) (CUSIP Number) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B253360 T |
|
| August 8, 2024 |
PROC / Procaps Group S.A. / Hoche Partners Pharma Holding S.A. - AMENDMENT Activist Investment SC 13D/A 1 procaps13da5.htm AMENDMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 5) Procaps Group, S.A. (Name of Issuer) Ordinary Shares, nominal value of $0.01 per share (Title of Class of Securities) L7756P 102 (Ordinary Shares) (CUSIP Number) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of L |
|
| July 29, 2024 |
Exhibit 99.15 Peter Flagel Director Gibbons P.C. One Pennsylvania Plaza 45th Floor, Suite 4515 New York, NY 10119 Direct: 212-613-2091 Fax: 212-554-9685 [email protected] July 29, 2024 VIA EMAIL Procaps Group S.A. 9 Rue De Bitbourg L-1273 Luxembourg Grand Duchy of Luxembourg Mr. Jose Antonio Vieira, Chief Executive Officer Board of Directors: Mr. Kyle P. Bransfield Mr. Luis Fernando Castro Mr |
|
| July 29, 2024 |
PROC / Procaps Group S.A. / Hoche Partners Pharma Holding S.A. - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 4) Procaps Group, S.A. (Name of Issuer) Ordinary Shares, nominal value of $0.01 per share (Title of Class of Securities) L7756P 102 (Ordinary Shares) (CUSIP Number) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B253360 T |
|
| July 22, 2024 |
PROC / Procaps Group S.A. / Hoche Partners Pharma Holding S.A. - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 3) Procaps Group, S.A. (Name of Issuer) Ordinary Shares, nominal value of $0.01 per share (Title of Class of Securities) L7756P 102 (Ordinary Shares) (CUSIP Number) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B253360 T |
|
| July 22, 2024 |
Exhibit 99.14 Peter Flagel Director Gibbons P.C. One Pennsylvania Plaza 45th Floor, Suite 4515 New York, NY 10119 Direct: 212-613-2091 Fax: 212-554-9685 [email protected] July 18, 2024 VIA EMAIL Procaps Group S.A. 9 Rue De Bitbourg L-1273 Luxembourg Grand Duchy of Luxembourg Mr. Jose Antonio Vieira, Chief Executive Officer Board of Directors: Mr. Kyle P. Bransfield Mr. Luis Fernando Castro Mr |
|
| July 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B |
|
| June 28, 2024 |
Exhibit 99.1 Procaps Group Announces New Chairman Ruben Minski decides to stepdown as Executive Chairman and José Minski is appointed as new Chairman of the Board MIAMI, USA – BARRANQUILLA, COL – June 28, 2024 – Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that Mr. Ruben Minski has resigned from hi |
|
| June 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B |
|
| May 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B2 |
|
| May 20, 2024 |
Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F Exhibit 99.1 Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F MIAMI, USA – BARRANQUILLA, COL – May 20, 2024 – Procaps Group (Nasdaq: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has received a letter from the Nasdaq Stock Market, dated May 16, 2024 (the “Delinquency Letter”), notif |
|
| May 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B2 |
|
| May 14, 2024 |
Procaps Group Delays Filing of Annual Report on Form 20-F Exhibit 99.1 Procaps Group Delays Filing of Annual Report on Form 20-F MIAMI, USA – BARRANQUILLA, COL – May 14, 2024 – Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has determined it is unable to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2023, within the |
|
| May 1, 2024 |
Procaps Group Delays Filing of Annual Report on Form 20-F Exhibit 99.1 Procaps Group Delays Filing of Annual Report on Form 20-F MIAMI, USA – BARRANQUILLA, COL – May 1, 2024 – Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has determined it is unable to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2023, within the p |
|
| May 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B2 |
|
| May 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-40851 CUSIP NUMBER L7756P 102 (Check one): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tr |
|
| March 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: |
|
| March 4, 2024 |
Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives Exhibit 99.1 Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives MIAMI, USA – BARRANQUILLA, COL – March 04, 2024 – Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it is conducting a process to explore strategic alternatives to maximize shareholder value. |
|
| February 20, 2024 |
PROC / Procaps Group S.A. / Hoche Partners Pharma Holding S.A. - SC 13D/A Activist Investment SC 13D/A 1 procaps13da2.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2) Procaps Group, S.A. (Name of Issuer) Ordinary Shares, nominal value of $0.01 per share (Title of Class of Securities) L7756P 102 (Ordinary Shares) (CUSIP Number) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Lu |
|
| February 20, 2024 |
HOCHE PARTNERS PHARMA HOLDING S.A. EX-99.10 2 ex9910.htm EXHIBIT 99.10 Exhibit 99.10 HOCHE PARTNERS PHARMA HOLDING S.A. 58, rue Charles Martel L-2134 Luxembourg To: Procaps Group, S.A. - Board of Directors 9, rue De Bitbourg L-1273 Luxembourg Grand Duchy of Luxembourg (the Company or Procaps) With a copy to its statutory auditor Mr. Carlos Piocuda 78 B 201, Calle 80 080001, Barranquilla, Colombie February 12, 2024 Dear Sirs: We are |
|
| January 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg |
|
| January 16, 2024 |
Exhibit 99.1 January 15, 2024 Dear Shareholders, We became aware on Saturday, January 13, 2024, that the online voting instructions related to the upcoming General Meeting of Shareholders of the Company scheduled for January 22, 2024, were incorrect. Notwithstanding the Company’s diligent review of all relevant materials, a third party unilaterally included on the online version an inaccurate stat |
|
| January 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg |
|
| January 12, 2024 |
Procaps Group S.A. - Board of Directors EX-99.7 2 ex997.htm EXHIBIT 99.7 Exhibit 99.7 To: Procaps Group S.A. - Board of Directors 9, rue De Bitbourg L-1273 Luxembourg Grand Duchy of Luxembourg (the Company) With a copy to its statutory auditor Mr. Carlos Piocuda 78 B 201, Calle 80 080001, Barranquilla, Colombie 7 December 2023 Dear Sirs: We refer to the email dated 4 December 2023 from Mr. Canio Corbo of CHL Capital addressed to the cha |
|
| January 12, 2024 |
LU2376511205 / PROCAPS GROUP SA / Hoche Partners Pharma Holding S.A. - SC 13D/A Activist Investment SC 13D/A 1 procaps13da1.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1) Procaps Group, S.A. (Name of Issuer) Ordinary Shares, nominal value of $0.01 per share (Title of Class of Securities) L7756P 102 (Ordinary Shares) (CUSIP Number) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Lu |
|
| January 12, 2024 |
Procaps Group S.A. - Board of Directors EX-99.8 3 ex998.htm EXHIBIT 99.8 Exhibit 99.8 To: Procaps Group S.A. - Board of Directors 9, rue De Bitbourg L-1273 Luxembourg Grand Duchy of Luxembourg (the Company or Procaps) With a copy to its statutory auditor Mr. Carlos Piocuda 78 B 201, Calle 80 080001, Barranquilla, Colombie 25 December 2023 Dear Sirs: We are in receipt of your lawyers’ letter dated December 22, 2023. Our lawyers will prom |
|
| January 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg |
|
| January 5, 2024 |
Exhibit 99.1 Dear Shareholders, We hereby inform you that, at the request of a shareholder, a general meeting of shareholders (the “General Meeting”) of Procaps Group, S.A., a public limited liability company (société anonyme) incorporated and existing under the laws of the Grand Duchy of Luxembourg, having its registered office at 9, rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg, |
|
| January 5, 2024 |
Exhibit 99.2 |
|
| December 26, 2023 |
Exhibit 99.1 Procaps Group, S.A. and subsidiaries (The Group) Unaudited Condensed Consolidated Interim Financial Statements For the three and nine months ended September 30, 2023 and 2022 Procaps Group, S.A. and subsidiaries (The Group) Unaudited Condensed Consolidated Interim Statement of Profit or Loss and Other Comprehensive Income For the three and nine months ended September 30, 2023 and 2022 |
|
| December 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| December 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| December 26, 2023 |
Exhibit 99.1 Procaps Group Reports Third Quarter 2023 Results Net Revenues Increased 5% in 9M23 Year-over-Year on a Constant Currency Basis, Driven by 13% RX Growth MIAMI, USA – BARRANQUILLA, COL – December 26, 2023 – Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated international healthcare and pharmaceutical services company, today announced its financial resu |
|
| December 26, 2023 |
Exhibit 99.2 Third Quarter 2023 Financial Results Net Revenues Net revenues totaled $118.4 million in 3Q23 compared to net revenues of $110.4 million for 9M22, an increase of 7.3% year-over-year. On a constant currency basis net revenues increased by 2.3% from 3Q22 to 3Q23, totaling $112.9 million. Net revenues totaled $312.6 million for 9M23, an increase of 1.4% from 3Q22, impacted mainly by the |
|
| November 22, 2023 |
Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024 Exhibit 99.1 Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024 MIAMI, USA – BARRANQUILLA, COL – November 22, 2023 – Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today a strategic leadership transition as Ruben Minski, founder and CEO of Procaps prepares to transition from |
|
| November 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| October 23, 2023 |
Exhibit 99.1 Procaps Appoints Sandra Sánchez y Oldenhage to Board of Directors Experienced Pharma Professional Brings Wealth of International Industry and Governance Experience to Board MIAMI, USA – BARRANQUILLA, COL – October 23, 2023 – Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced the appointment |
|
| October 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg |
|
| September 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembou |
|
| September 7, 2023 |
Exhibit 99.1 Procaps Group Announces the Expansion of its Oncology Portfolio The Agreement Substantially Increases Procaps’ Participation in the Oncology Market in the LatAm Region MIAMI, USA – BARRANQUILLA, COL – September 7, 2023 – Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, announced today that it ha |
|
| September 5, 2023 |
Exhibit 99.1 Procaps Group Reports Second Quarter 2023 Results Net Revenues Increased 7% in 1H23 year-over-year on a constant currency basis, signaling positive performance of Rx products MIAMI, USA – BARRANQUILLA, COL – September 5, 2023 – Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated international healthcare and pharmaceutical services company, today annou |
|
| September 5, 2023 |
Exhibit 99.2 Second Quarter 2023 Financial Results Net Revenues Net revenues totaled $110.1 million in 2Q23, compared to net revenues of $112.4 million for 2Q22, a decrease of 2.1% year-over-year. On a constant currency basis, net revenues increased 4.3% from 2Q22 to 2Q23, totaling $117.3 million. In 2Q22 there was a recognition of sales of brands in the amount of approximately $3.5 million, leadi |
|
| September 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembou |
|
| September 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembou |
|
| September 5, 2023 |
Exhibit 99.1 Procaps Group, S.A. and subsidiaries (The Group) Unaudited Condensed Consolidated Interim Financial Statements For the three and six months ended June 30, 2023 and 2022 1 Procaps Group, S.A. and subsidiaries (The Group) Unaudited Condensed Consolidated Interim Statement of Profit or Loss and Other Comprehensive Income For the three and six months ended June 30, 2023 and 2022 (In thous |
|
| August 21, 2023 |
Exhibit 99.1 Procaps – Loan Agreement Execution Version Confidential LOAN AGREEMENT between Procaps S.A. (as Borrower) Procaps Group, S.A. C.I. Procaps S.A. Diabetrics Healthcare S.A.S. Procaps, S.A. de C.V. Funtrition S.A.S. (as Guarantors) and Bancolombia S.A. Banco Davivienda S.A. (As Lenders) August 16, 2023 Table of contents ARTICLE I. DEFINED TERMS And Rules Of Interpretation 2 Section 1.01 |
|
| August 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: |
|
| June 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B |
|
| June 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B |
|
| June 14, 2023 |
Exhibit 99.1 Dear Shareholders, I am pleased to inform you that the annual general meeting of shareholders (the “Annual General Meeting”) of Procaps Group, S.A., a public limited liability company (société anonyme) incorporated and existing under the laws of the Grand Duchy of Luxembourg, having its registered office at 9, rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg, and register |
|
| June 14, 2023 |
Exhibit 99.2 |
|
| June 6, 2023 |
Exhibit 99.1 Procaps Group Reports First Quarter 2023 Results Constant Currency Net Revenues Increased 10% Quarter-over-Quarter in 1Q23, and 22% increase in Adjusted EBITDA, With Strong Demand of RX and Softgel Portfolios, Offset by Clinical Specialty Covid Portfolio MIAMI, USA – BARRANQUILLA, COL – June 5, 2023 – Procaps Group, S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated international h |
|
| June 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B |
|
| June 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B |
|
| June 6, 2023 |
Exhibit 99.1 Procaps Group, S.A. and subsidiaries (The Group) Unaudited Condensed Consolidated Interim Financial Statements for the three months ended March 31, 2023 and 2022 1 Procaps Group, S.A. and subsidiaries (The Group) Unaudited Condensed Consolidated Interim Statement of Profit or Loss and Other Comprehensive Income For the three ended March 31, 2023 and 2022 (In thousands of United States |
|
| June 6, 2023 |
Exhibit 99.2 First Quarter 2023 Financial Results Net Revenues Net revenues totaled $84.2 million in 1Q23, compared to net revenues of $85.6 million for 1Q22, a decrease of 1.7% year-over-year. On a constant currency basis, net revenues increased 10.5% from 1Q22 to 1Q23, in line with previous preliminary results. The slight decrease is mainly driven by the impact of the devaluation of some local c |
|
| June 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B |
|
| June 1, 2023 |
23,375,000 ORDINARY SHARES and 99,978,689 ORDINARY SHARES Offered by Selling Securityholders Filed Pursuant to Rule 424(b)(3) Registration No. 333-261366 PROSPECTUS 23,375,000 ORDINARY SHARES and 99,978,689 ORDINARY SHARES Offered by Selling Securityholders This prospectus relates to the issuance by us of (i) 20,000,000 shares of our Ordinary Shares that may be issued upon exercise of warrants to purchase Ordinary Shares at an exercise price of $11.50 (the “Public Warrants”), and (ii) 3,3 |
|
| May 25, 2023 |
As filed with the Securities and Exchange Commission on May 25, 2023 As filed with the Securities and Exchange Commission on May 25, 2023 Registration No. |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B2 |
|
| May 15, 2023 |
Exhibit 99.1 1 4Q22 & 2022 Financial Results May 15, 2023 NASDAQ: PROC 2 DISCLAIMER Forward - Looking Statements This presentation includes "forward - looking statements . " Forward - looking statements may be identified by the use of words such as "forecast," "intend," "seek," "target," "anticipate," "believe," "expect," "estimate," "plan," "outlook," and "project" and other similar expressions t |
|
| May 12, 2023 |
Exhibit 99.1 Procaps Group Reports Fourth Quarter and Full Year 2022 Results Constant Currency Net Revenues Increased 7% Year-over-Year in 2022, With Strong Demand of RX and Softgel Portfolios, Offset by Clinical Specialty Covid Portfolio Preliminary Results for 1Q23 Results Show a Significant Rebound from 4Q22 Performance, as We Expect to Reach at Least High Single-Digit Growth in Adj. EBITDA Man |
|
| May 12, 2023 |
Exhibit 4.17 Gentlemen PROCAPS S.A. Attention: Carlos Piocuda Address: Calle 80 # 78B – 201, Barranquilla, Colombia [email protected] May 2, 2023 Waiver and Consent Dear Sirs, We refer to: (a) To the credit agreement entered into on November 20, 2018 (as amended by Addendum No. 1 dated December 17, 2018 and Addendum No. 2 dated June 15, 2020 and as the same may be amended from time to time |
|
| May 12, 2023 |
Exhibit 4.18 Execution Version WAIVER AGREEMENT THIS WAIVER AGREEMENT (this “Agreement”), dated as of March 31, 2023, is entered into by and among Procaps S.A., a sociedad anónima organized under the laws of Colombia (the “Company”), Procaps Group, S.A., a société anonyme incorporated under the laws of the Grand Duchy of Luxembourg and having its registered office at 9 rue de Bitbourg, L-1273 Luxe |
|
| May 12, 2023 |
AMENDMENT NO. 1 TO THE CREDIT AGREEMENT Exhibit 4.10 CERTIFIED translation no. 157-2022. This is a CERTIFIED translation of a document written in Spanish, which is identified with the seal of the translator. This translation was prepared by Mariana Elena calderón medina, CERTIFIED interpreter and translator pursuant to THE CERTIFICATE Of PROFESSIONAL QUALIFICATION ON CERTIFIED TRANSLATIONS AND INTERPRETationS NO. 0313 ISSUED BY “Univers |
|
| May 12, 2023 |
Exhibit 12.2 CERTIFICATION I, Patricio Vargas Muñoz, certify that: 1. I have reviewed this annual report on Form 20-F of Procaps Group, S.A.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with re |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B2 |
|
| May 12, 2023 |
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Procaps Group, S.A. (the “Company”) on Form 20-F for the fiscal year ended December 31, 2022, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Ruben Minski, Chief Executive Off |
|
| May 12, 2023 |
Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Procaps Group, S.A. (the “Company”) on Form 20-F for the fiscal year ended December 31, 2022, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Patricio Vargas Muñoz, Chief Finan |
|
| May 12, 2023 |
Exhibit 4.11 CERTIFIED translation no. 158-2022. This is a CERTIFIED translation of a document written in Spanish, which is identified with the seal of the translator. This translation was prepared by Mariana Elena calderón medina, CERTIFIED interpreter and translator pursuant to THE CERTIFICATE Of PROFESSIONAL QUALIFICATION ON CERTIFIED TRANSLATIONS AND INTERPRETationS NO. 0313 ISSUED BY “Univers |
|
| May 12, 2023 |
Exhibit 4.9 CERTIFIED translation no. 155-2022. This is a CERTIFIED translation of a document written in Spanish, which is identified with the seal of the translator. This translation was prepared by Mariana Elena calderón medina, CERTIFIED interpreter and translator pursuant to THE CERTIFICATE Of PROFESSIONAL QUALIFICATION ON CERTIFIED TRANSLATIONS AND INTERPRETationS NO. 0313 ISSUED BY “Universi |
|
| May 12, 2023 |
Exhibit 12.1 CERTIFICATION I, Ruben Minski, certify that: 1. I have reviewed this annual report on Form 20-F of Procaps Group, S.A.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O |
|
| May 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-40851 CUSIP NUMBER L7756P 102 (Check one): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tr |
|
| February 13, 2023 |
Exhibit 99.1 Procaps Issues Shareholder Letter and Provides Preliminary Fiscal Year 2022 Financial Results and 2023 Guidance Reports Preliminary Financial Estimates for Net Revenue and Adjusted EBITDA for Full Year 2022 Realigns Board of Directors to Focus on Profitable Growth Announces $5M+ Share Repurchase Program Commences $15MM Cost Reduction Plan to Improve Margins and Financial Performance 2 |
|
| February 13, 2023 |
6-K 1 ea173375-6kprocaps.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg |
|
| January 19, 2023 |
EX-99.1 2 ea171944ex99-1procaps.htm PRESS RELEASE OF PROCAPS GROUP, S.A. DATED JANUARY 19, 2023 Exhibit 99.1 Procaps Announces Key Changes to the Board of Directors International Corporate Executive and Attorney Alberto Eguiguren Correa Appointed to Board of Directors MIAMI, USA – BARRANQUILLA, COL – January 19, 2023 – Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated |
|
| January 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg |
|
| January 11, 2023 |
Termination Letter, Dated January 10, 2023 Exhibit 10.1 January 10, 2023 The Addressees listed in Schedule 1 hereto Re: Procaps $485,000,000 Credit Agreement - Termination Letter Ladies and Gentlemen: Reference is made to (i) that certain Credit Agreement dated as of October 11, 2022 (the “Credit Agreement”) among Procaps Group, S.A., as borrower (the “Borrower”), the guarantors from time to time party thereto (collectively, the “Guarantor |
|
| January 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg |
|
| January 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg |
|
| January 10, 2023 |
Exhibit 99.1 One of the fastest growing and innovative Pharma organizations in Latin America JP Morgan Healthcare Conference January 10, 2023 NASDAQ: PROC 1 DISCLAIMER 2 Projections This presentation was prepared for informational purposes only by Procaps Group, S . A . , a public limited liability company (société anonyme) governed by the laws of the Grand Duchy of Luxembourg (the “Company”) and |
|
| January 3, 2023 |
Exhibit 99.1 Procaps Group Announces Termination of Acquisition Agreement with Grupo Somar Company to Provide 2023 Value Creation Plan at J.P. Morgan Healthcare Conference MIAMI, USA ? BARRANQUILLA, COL ? January 3, 2023 ? Procaps Group, S.A. (NASDAQ: PROC) (?Procaps? or the ?Company?), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced the termination of its pr |
|
| January 3, 2023 |
6-K 1 ea171110-6kprocaps.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, |
|
| December 29, 2022 |
Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference Exhibit 99.1 Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference MIAMI, USA ? BARRANQUILLA, COL ? December 29, 2022 ? Procaps Group, S.A. (NASDAQ: PROC) (?Procaps? or the ?Company?), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced that it will present at the 2023 J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 8:00 am PST. A |
|
| December 29, 2022 |
6-K 1 ea170969-6kprocaps.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg |
|
| December 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant?s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| December 22, 2022 |
Update on Proposed Acquisition of Grupo Somar Exhibit 99.1 Update on Proposed Acquisition of Grupo Somar MIAMI, USA ? BARRANQUILLA, COL ? December 22, 2022 ? Procaps Group, S.A. (NASDAQ: PROC) (?Procaps? or the ?Company?), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announces an update on its previously reported definitive agreement, dated as of May 16, 2022 (the ?SPA?), to acquire Grupo Somar (including Grupo Farma |
|
| November 16, 2022 |
6-K 1 ea168844-6kprocaps.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg |
|
| November 16, 2022 |
EX-99.1 2 ea168844ex99-1procaps.htm EARNINGS PRESENTATION OF PROCAPS GROUP, S.A., DATED NOVEMBER 16, 2022 - 3Q22 &9M22 FINANCIAL RESULTS Exhibit 99.1 1 3Q22 & 9M22 Financial Results November 16, 2022 NASDAQ: PROC 2 DISCLAIMER Forward - Looking Statements This presentation includes “forward - looking statements . ” Forward - looking statements may be identified by the use of words such as "forecast |
|
| November 15, 2022 |
424B3 1 ea168590-424b3procaps.htm PROSPECTUS SUPPLEMENT Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-261366 November 14, 2022 PROSPECTUS SUPPLEMENT NO. 6 23,375,000 ORDINARY SHARES and 110,303,689 ORDINARY SHARES Offered by Selling Securityholders This prospectus supplement amends the prospectus dated May 6, 2022, as supplemented on May 24, 2022, June 15, 2022, August 30, 2022, |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| November 14, 2022 |
EX-99.2 3 ea168589ex99-2procaps.htm THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS OF PROCAPS GROUP, S.A. AS OF SEPTEMBER 30, 2022 AND FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021 Exhibit 99.2 Procaps Group S.A. and subsidiaries (The Group) Unaudited Condensed Consolidated Interim Financial Statements for the three and nine months ended September 30, 2022 and |
|
| November 14, 2022 |
EX-99.1 2 ea168589ex99-1procaps.htm PRESS RELEASE OF PROCAPS GROUP, S.A. DATED NOVEMBER 14, 2022 - PROCAPS GROUP REPORTS THIRD QUARTER AND NINE MONTHS 2022 RESULTS Exhibit 99.1 Procaps Group Reports Third Quarter and Nine Months 2022 Results Constant currency Net Revenues Increased by 15% year-over-year in the 9M22 and by 11% in the 3Q22, signaling a strong demand across our businesses MIAMI, USA |
|
| November 4, 2022 |
Exhibit 10.1 CLIFFORD CHANCE US LLP Execution Version Dated as of October 11, 2022 by and among PROCAPS GROUP, S.A., as Borrower, the Guarantors from time to time party hereto, THE BANK OF NEW YORK MELLON, as Administrative Agent and Collateral Agent, the Lenders from time to time party hereto, and BofA SECURITIES, INC., JPMORGAN CHASE BANK, N.A., MORGAN STANLEY SENIOR FUNDING, INC., as Joint Lead |
|
| November 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| November 4, 2022 |
424B3 1 ea168081-424b3procaps.htm FORM 424B3 Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-261366 November 4, 2022 PROSPECTUS SUPPLEMENT NO. 5 23,375,000 ORDINARY SHARES and 110,303,689 ORDINARY SHARES Offered by Selling Securityholders This prospectus supplement amends the prospectus dated May 6, 2022, as supplemented on May 24, 2022, June 15, 2022, August 30, 2022 and September |
|
| November 4, 2022 |
EX-4.1 2 ea168037ex4-1procaps.htm NOTE PURCHASE AND GUARANTEE AGREEMENT, DATED NOVEMBER 5, 2021 BY AND AMONG PROCAPS S.A., PROCAPS GROUP, S.A. Exhibit 4.1 Execution Version PROCAPS S.A. US$115,000,000 Guaranteed Senior Notes due NOVEMBER 12, 2031 Guaranteed by PROCAPS GROUP, S.A., as Parent Guarantor, AND certain Subsidiary Guarantors Note Purchase and Guarantee Agreement Dated NOVEMBER 5, 2021 TA |
|
| November 4, 2022 |
EX-4.4 5 ea168037ex4-4procaps.htm WAIVER AND THIRD AMENDMENT TO NOTE PURCHASE AND GUARANTEE AGREEMENT, DATED AS OF NOVEMBER 1, 2022, BY AND AMONG PROCAPS S.A., PROCAPS GROUP, S.A. Exhibit 4.4 Execution Version WAIVER AND THIRD AMENDMENT TO NOTE PURCHASE AND GUARANTEE AGREEMENT THIS WAIVER AND THIRD AMENDMENT TO NOTE PURCHASE AND GUARANTEE AGREEMENT (this “Agreement”), dated as of November 1, 2022, |
|
| November 4, 2022 |
Exhibit 4.3 Execution Version Second AMENDMENT TO Note purchase AND GUARANTEE agreement THIS SECOND AMENDMENT TO NOTE PURCHASE AND GUARANTEE AGREEMENT (this ?Agreement?), dated as of February 28, 2022, is entered into by and among Procaps S.A., a sociedad an?nima organized under the laws of Colombia (the ?Company?), Procaps Group, S.A., a soci?t? anonyme incorporated under the laws of the Grand Du |
|
| November 4, 2022 |
EX-4.2 3 ea168037ex4-2procaps.htm FIRST AMENDMENT TO NOTE PURCHASE AND GUARANTEE AGREEMENT, DATED AS OF JANUARY 12, 2022, BY AND AMONG PROCAPS S.A., PROCAPS GROUP, S.A. Exhibit 4.2 Execution Version First AMENDMENT TO Note purchase AND GUARANTEE agreement THIS FIRST AMENDMENT TO NOTE PURCHASE AND GUARANTEE AGREEMENT (this “Agreement”), dated as of January 12, 2022, is entered into by and among Pro |
|
| October 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg |
|
| September 2, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-261366 September 2, 2022 PROSPECTUS SUPPLEMENT NO. 4 23,375,000 ORDINARY SHARES and 110,303,689 ORDINARY SHARES Offered by Selling Securityholders This prospectus supplement amends the prospectus dated May 6, 2022, as supplemented on May 24, 2022, June 15, 2022 and August 30, 2022 (the ?Prospectus?), of Procaps Group, S.A., a public l |
|
| September 2, 2022 |
Acknowledgement Letter of Deloitte & Touche Ltda. Exhibit 15.1 September 1, 2022 The shareholders and the Board of Directors of Procaps Group, S.A. 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B253360 We are aware that our report dated August 26, 2022 on our review of the interim financial information of Procaps Group, S.A. appearing in this Prospectus Supplement, is incorporated by reference in Registration S |
|
| August 31, 2022 |
Exhibit 99.1 1 2Q22 & 1H22 Financial Results August 29, 2022 NASDAQ: PROC 2 3 Team Members Presenting Today Ruben Minski Founder ? Chairman ? Chief Executive Officer Founder, President and Director (44 years) Chemical Engineering Owners / President Management Program Finance Vice President & Treasurer Chief Executive Officer Chief Financial Officer MBA Electrical & Industrial Engineering Patricio |
|
| August 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant?s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: |
|
| August 30, 2022 |
Exhibit 99.1 Procaps Group Reports Second Quarter and First Half 2022 Results Net Revenues Increased 14% year-over-year in the Second Quarter, with Adjusted EBITDA Margin of 24% Constant currency Net Revenues Increased by 18% year-over-year in the First Half, signaling a strong demand across our businesses MIAMI, USA – BARRANQUILLA, COL – August 30, 2022 – Procaps Group S.A. (NASDAQ: PROC) (“Proca |
|
| August 30, 2022 |
Exhibit 99.2 Procaps Group S.A. and subsidiaries (The Group) Unaudited Condensed Consolidated Interim Financial Statements for the three and six months ended June 30, 2022 and 2021 1 Deloitte & Touche Ltda. Nit. 860.005.813-4 Calle 76 No. 54-11 Of. 1101/1102/1104 Ed. World Trade Center Barranquilla Colombia Tel: +57 (605) 366 9650 www.deloitte.com/co REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNT |
|
| August 30, 2022 |
424B3 1 ea165141-424b3procapsgroup.htm PROSPECTUS SUPPLEMENT Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-261366 August 30, 2022 PROSPECTUS SUPPLEMENT NO. 3 23,375,000 ORDINARY SHARES and 110,303,689 ORDINARY SHARES Offered by Selling Securityholders This prospectus supplement amends the prospectus dated May 6, 2022, as supplemented on May 24, 2022 and June 15, 2022 (the “Prospe |
|
| August 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: |
|
| August 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: |
|
| August 30, 2022 |
Procaps Group to Host Second Quarter and First Half 2022 Conference Call on Wednesday Exhibit 99.1 Procaps Group to Host Second Quarter and First Half 2022 Conference Call on Wednesday MIAMI, USA - BARRANQUILLA, COL – August 30, 2022 – Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that will host a conference call and webcast at 12 p.m. Eastern time, on August 31, 2022, to discuss the second quarter and fir |
|
| June 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B |
|
| June 29, 2022 |
Exhibit 99.1 1 One of the fastest growing and innovative Pharma organizations in Latin America June, 2022 NASDAQ: PROC 2 DISCLAIMER This presentation was prepared for informational purposes only by Procaps Group, S . A . , a public limited liability company (soci?t? anonyme) governed by the laws of the Grand Duchy of Luxembourg and contains financial forecasts with respect to certain financial met |
|
| June 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B |
|
| June 15, 2022 |
Exhibit 99.1 Procaps Group S.A. and subsidiaries (The Group) Unaudited Condensed Consolidated Interim Financial Statements for the three months ended March 31, 2022 and 2021 Procaps Group S.A. and subsidiaries (The Group) Unaudited Condensed Consolidated Interim Statement of Profit or Loss and Other Comprehensive Income For the three months ended March 31, 2022 and 2021 (In thousands of United Sta |
|
| June 15, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-261366 June 15, 2022 PROSPECTUS SUPPLEMENT NO. 2 23,375,000 ORDINARY SHARES and 110,303,689 ORDINARY SHARES Offered by Selling Securityholders This prospectus supplement amends the prospectus dated May 6, 2022, as supplemented on May 24, 2022 (the ?Prospectus?), of Procaps Group, S.A., a public limited liability company (soci?t? anony |
|
| June 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant?s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B |
|
| June 2, 2022 |
EX-99.1 2 ea161050ex99-1procapsgroup.htm PRESS RELEASE OF PROCAPS GROUP S.A., DATED JUNE 2, 2022 - PROCAPS GROUP REPORTS PRELIMINARY FIRST QUARTER 2022 RESULTS Exhibit 99.1 Procaps Group Reports Preliminary First Quarter 2022 Results Net Revenues Increased by 11% to U$ 86 million, with Adjusted EBITDA Up 15% Year-Over-Year to $9 Million MIAMI, FL – BARRANQUILLA, COL – June 2, 2022 – Procaps Group |
|
| June 2, 2022 |
6-K 1 ea161050-6kprocapsgroup.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbour |
|
| June 1, 2022 |
Exhibit 99.1 Dear Shareholders, I am pleased to inform you that the annual general meeting of shareholders (the ?Annual General Meeting?) of Procaps Group, S.A., a public limited liability company (soci?t? anonyme) incorporated and existing under the laws of the Grand Duchy of Luxembourg, having its registered office at 9, rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg, and register |
|
| June 1, 2022 |
6-K 1 ea160875-6kprocaps.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1 |
|
| June 1, 2022 |
Form of Proxy Card for the Annual General Meeting of Shareholders of Procaps Group, S.A. Exhibit 99.2 |
|
| May 24, 2022 |
424B3 1 ea160414-424b3procaps.htm PROSPECTUS SUPPLEMENT Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-261366 May 24, 2022 PROSPECTUS SUPPLEMENT NO. 1 23,375,000 ORDINARY SHARES and 110,303,689 ORDINARY SHARES Offered by Selling Securityholders This prospectus supplement amends the prospectus dated May 6, 2022 (the “Prospectus”), of Procaps Group, S.A., a public limited liability |
|
| May 20, 2022 |
6-K 1 ea160413-6kprocapsgro.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, |
|
| May 19, 2022 |
Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Procaps Group, S.A. (the “Company”) on Form 20-F for the fiscal year ended December 31, 2021, as filed with the U.S. Securities and Exchange Commission (the “Report”), I, Patricio Vargas Muñoz, Chief Financial Officer, certi |
|
| May 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F/A (Amendment No. 1) ☐ Registration Statement Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Fiscal Year Ended December 31, 2021 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities |
|
| May 19, 2022 |
Exhibit 12.1 CERTIFICATION I, Ruben Minski, certify that: 1. I have reviewed this annual report on Form 20-F of Procaps Group, S.A.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to |
|
| May 19, 2022 |
Exhibit 12.2 CERTIFICATION I, Patricio Vargas Muñoz, certify that: 1. I have reviewed this annual report on Form 20-F of Procaps Group, S.A.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with re |
|
| May 19, 2022 |
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Procaps Group, S.A. (the “Company”) on Form 20-F for the fiscal year ended December 31, 2021, as filed with the U.S. Securities and Exchange Commission (the “Report”), I, Ruben Minski, Chief Executive Officer, certify, purs |
|
| May 18, 2022 |
6-K 1 ea160212-6kprocaps.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1 |
|
| May 18, 2022 |
EX-99.1 2 ea160212ex99-1procaps.htm INVESTOR PRESENTATION OF PROCAPS GROUP S.A., DATED MAY 18, 2022 Exhibit 99.1 1 Acquisition of Grupo Somar May 2022 Establishing Procaps as one of the Fastest Growing Pharma Consolidators in Latin America Disclaimer 2 Use of Projections This presentation was prepared for informational purposes only by Procaps Group, S . A . , a public limited liability company (s |
|
| May 17, 2022 |
EX-99.1 2 ea160043ex99-1procaps.htm PRESS RELEASE OF PROCAPS GROUP S.A., DATED MAY 17, 2022 - PROCAPS GROUP TO ACQUIRE GRUPO SOMAR (INCLUDING QUIMICA Y FARMACIA, GELCAPS AND RELATED ENTITIES) FROM ADVENT INTERNATIONAL, GAINING AN IMPORTANT PRESENCE IN MEXICO Exhibit 99.1 Procaps Group to Acquire Grupo Somar (including Química y Farmacia, Gelcaps and related entities) from Advent International, gai |
|
| May 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B2 |
|
| May 6, 2022 |
23,375,000 ORDINARY SHARES and 110,303,689 ORDINARY SHARES Offered by Selling Securityholders Filed Pursuant to Rule 424(b)(3) Registration No.: 333-261366 PROSPECTUS 23,375,000 ORDINARY SHARES and 110,303,689 ORDINARY SHARES Offered by Selling Securityholders This prospectus relates to the issuance by us of (i) 20,000,000 shares of our Ordinary Shares that may be issued upon exercise of warrants to purchase Ordinary Shares at an exercise price of $11.50 (the ?Public Warrants?), and (ii) 3 |
|
| May 5, 2022 |
6-K 1 ea159498-6kprocaps.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1 |
|
| May 5, 2022 |
EX-99.1 2 ea159498ex99-1procaps.htm FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS Exhibit 99.1 1 May 5, 2022 NASDAQ: PROC Fourth Quarter & Full Year 2021 Financial Results 2 Forward Looking Statements Use of Projections This presentation was prepared for informational purposes only by Procaps Group, S . A . , a public limited liability company (société anonyme) governed by the laws of the Gr |
|
| May 4, 2022 |
As filed with the Securities and Exchange Commission on May 3, 2022 POS AM 1 ea159287-posamprocaps.htm POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 As filed with the Securities and Exchange Commission on May 3, 2022 Registration No. 333-261366 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Procaps Group, S.A. (Exact name of Registrant as specified in its cha |
|
| May 2, 2022 |
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Procaps Group, S.A. (the “Company”) on Form 20-F for the fiscal year ended December 31, 2021, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Ruben Minski, Chief Executive Off |
|
| May 2, 2022 |
Exhibit 99.1 Procaps Group Reports Fourth Quarter and Fiscal Year 2021 Financial Results Fiscal Year 2021 Net Revenues Increased 23.6% to $409.7 Million, with Adjusted EBITDA Up 17.8% Year-Over-Year to $99.7 Million Strong Double Digit 2021 Revenue Growth in All Business Units Driven by Market Share Gains and New Product Launches Company to Host Business Update Call on Thursday May 5, 2022, at 10 |
|
| May 2, 2022 |
6-K 1 ea159125-6kprocapsgroup.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbou |
|
| May 2, 2022 |
Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Procaps Group, S.A. (the “Company”) on Form 20-F for the fiscal year ended December 31, 2021, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Patricio Vargas Muñoz, Chief Finan |
|
| May 2, 2022 |
Exhibit 99.2 Procaps Group S.A. and subsidiaries (The Group) Unaudited Consolidated Statement of Profit or Loss and Other Comprehensive Income For the years ended December 31, 2021, 2020 and 2019 (In thousands of United States Dollars, unless otherwise stated) For the year ended December 31 Notes 2021 2020 2019 Revenue 7 $ 409,742 $ 331,467 $ 324,792 Cost of sales (174,029 ) (140,153 ) (142,294 ) |
|
| May 2, 2022 |
Exhibit 12.2 CERTIFICATION I, Patricio Vargas Muñoz, certify that: 1. I have reviewed this annual report on Form 20-F of Procaps Group, S.A.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with re |
|
| May 2, 2022 |
424B3 1 ea159127-424b3procaps.htm PROSPECTUS SUPPLEMENT Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-261366 April 29, 2022 PROSPECTUS SUPPLEMENT NO. 2 23,375,000 ORDINARY SHARES and 110,303,689 ORDINARY SHARES Offered by Selling Securityholders This prospectus supplement amends the prospectus dated December 6, 2021, as supplemented on December 10, 2021 (the “Prospectus”) of Proc |
|
| May 2, 2022 |
Exhibit 12.1 CERTIFICATION I, Ruben Minski, certify that: 1. I have reviewed this annual report on Form 20-F of Procaps Group, S.A.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to |
|
| May 2, 2022 |
EX-2.5 2 f20f2021ex2-5procapsgroup.htm DESCRIPTION OF SECURITIES Exhibit 2.5 Description of Securities We are a public limited liability company (société anonyme) governed by the laws of the Grand Duchy of Luxembourg (the “Company”). The following is a summary of the material terms of our ordinary shares, nominal value $0.01 per share (the “Ordinary Shares”) and our warrants entitling the holder t |
|
| May 2, 2022 |
20-F 1 f20f2021procapsgroup.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTIO |
|
| February 14, 2022 |
LU2376511205 / PROCAPS GROUP SA / International Finance Corp - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* PROCAPS GROUP S.A. (Name of Issuer) Ordinary Shares, nominal value $0.01 per share (Title of Class of Securities) L7756P102 (CUSIP Number) September 29, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th |
|
| February 2, 2022 |
EX-99.1 2 ea154837ex99-1procaps.htm PRESS RELEASE OF PROCAPS GROUP, S.A. ANNOUNCING CAPACITY EXPANSION PLANS IN THE UNITED STATES WITH THE CONSTRUCTION OF A NEW GUMMY MANUFACTURING FACILITY IN FLORIDA. Exhibit 99.1 Procaps Group Announces Capacity Expansion Plans in the United States with Construction of New Gummy Manufacturing Facility in Florida New Funtrition Gummy Manufacturing Facility in Flo |
|
| February 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| January 31, 2022 |
Exhibit 99.1 Procaps Group Announces Appointment of Melissa Angelini as Investor Relations Director Pharmaceutical Industry and Investor Relations Veteran to Lead Capital Markets Communications Strategy BARRANQUILLA, COLOMBIA ? January 28, 2022 ? Procaps Group (NASDAQ: PROC), a leading integrated international healthcare and pharmaceutical company, today announced the appointment of Melissa Angeli |
|
| January 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg |
|
| January 12, 2022 |
EX-99.1 2 ea153865ex99-1procapsgroup.htm PRESS RELEASE OF PROCAPS GROUP, S.A. ANNOUNCING THE ACQUISITION OF ITS FIRST US-BASED SOFTGEL PRODUCTION FACILITY AND PHARMACEUTICAL R&D CENTER Exhibit 99.1 Procaps Group Acquires 1st U.S.-Based Softgel Production Facility and Pharmaceutical R&D Center to Expand Global Growth of its iCDMO Business Unit Top 5 Global Producer of Pharmaceutical Softgels to Exp |
|
| January 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2022 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant?s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg |
|
| December 17, 2021 |
EX-99.1 2 ea152447ex99-1procaps.htm UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE PERIODS ENDED SEPTEMBER 30, JUNE 30 AND MARCH 31, 2021 Exhibit 99.1 Procaps Group S.A. and subsidiaries (The Group) Unaudited Condensed Consolidated Interim Financial Statements for the periods ended September 30, June 30 and March 31, 2021 Procaps Group S.A. and subsidiaries (The Group) Unaud |
|
| December 17, 2021 |
6-K 1 ea152447-6kprocaps.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2021 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg |
|
| December 10, 2021 |
Exhibit 99.1 Procaps Group S.A. and subsidiaries (The Group) Unaudited Condensed Consolidated Interim Statement of Financial Position As of September 30, 2021 and December 31, 2020 (In thousands of United States Dollars, unless otherwise stated) As of September 30, 2021 As of December 31, 2020 Assets Non-current assets Property, plant and equipment, net $ 71,259 70,335 Right-of-use assets 36,645 4 |
|
| December 10, 2021 |
Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-261366 December 10, 2021 PROSPECTUS SUPPLEMENT NO. 1 23,375,000 ORDINARY SHARES and 110,303,689 ORDINARY SHARES Offered by Selling Securityholders This prospectus supplement amends the prospectus dated December 6, 2021 (the “Prospectus”) of Procaps Group, S.A., a public limited liability company (société anonyme) governed by the laws |
|
| December 10, 2021 |
6-K 1 ea152086-6kprocaps.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2021 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg |
|
| December 6, 2021 |
23,375,000 ORDINARY SHARES and 110,303,689 ORDINARY SHARES Offered by Selling Securityholders PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No.: 333-261366 23,375,000 ORDINARY SHARES and 110,303,689 ORDINARY SHARES Offered by Selling Securityholders This prospectus relates to the issuance by us of (i) 20,000,000 shares of our Ordinary Shares that may be issued upon exercise of warrants to purchase Ordinary Shares at an exercise price of $11.50 (the ?Public Warrants?), and (ii) 3 |
|
| December 2, 2021 |
9 rue de Bitbourg, L-1273 Grand Duchy of Luxembourg R.C.S. Luxembourg: B253360 CORRESP 1 filename1.htm 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B253360 December 2, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Procaps Group, S.A. Registration Statement on Form F-1 Filed November 24, 2021 File No. 333-261366 Ladies and Gentlemen: Procaps Gro |
|
| November 24, 2021 |
As filed with the Securities and Exchange Commission on November 24, 2021 Registration No. |
|
| November 24, 2021 |
List of Subsidiaries of Procaps Group, S.A. Exhibit 21.1 Subsidiaries of Procaps Group, S.A. Subsidiary Jurisdiction Union Acquisition Corp. II, an exempted company incorporated under the laws of the Cayman Islands with registration number 345887 Cayman Islands Crynssen Pharma Group Limited, a private limited liability company registered and incorporated under the laws of Malta and, particularly, the Companies Act Cap. 386 with company regi |
|
| November 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-40851 Procaps Group, S.A. (Translation of registrant’s name in English) 9 rue de Bitbourg, L-1273 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembour |
|
| November 23, 2021 |
Exhibit 99.1 1 November 23, 2021 NASDAQ: PROC Third Quarter 2021 Financial Results Conference Call Forward Looking Statements 2 Use of Projections This presentation was prepared for informational purposes only by Procaps Group, S . A . , a public limited liability company (société anonyme) governed by the laws of the Grand Duchy of Luxembourg, having its registered office at 9 , rue de Bitbourg, L |
|
| November 19, 2021 |
EX-99.1 2 ea151081ex99-1procapsgroup.htm PRESS RELEASE OF PROCAPS GROUP, S.A. ANNOUNCING FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2021 Exhibit 99.1 Procaps Group Reports Record Third Quarter 2021 Financial Results Third Quarter 2021 Net Revenues Increased 35% to $106.8 Million Year-Over-Year with Adjusted EBITDA Up 27% Year-Over-Year to $24.5 Million First Nine Months Net Revenu |
